Dihydro-Resveratrol Attenuates Oxidative Stress, Adipogenesis and Insulin Resistance in In Vitro Models and High-Fat Diet-Induced Mouse Model via AMPK Activation
Nutrients · 2023
DOI: 10.3390/nu15133006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Chu-Shing Lam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Teaching and Research Division, School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong, China. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government of Hong Kong, Research Grants Council of the Hong Kong Special Administrative Region, China, Government of the Hong Kong Special Administrative Region.
Abstract (Originalsprache)
Management of obesity has become a prevalent strategy for preventing the diseases closely integrated with excess body weight such as diabetes over the last half century. Searching for therapeutic agents acting on oxidative stress, adipogenesis and insulin resistance is considered as an efficient approach to control obesity-related diseases. The present study was designed to examine the in vitro and in vivo effects of dihydro-resveratrol (DR2), a naturally occurring compound from Dendrobium medicinal plants, on oxidative stress aggravation, adipogenesis, lipogenesis and insulin sensitivity. We utilized an in vitro 3T3-L1 adipocyte differentiation model to show that DR2 could reduce pre-adipocyte maturation by activation of AMPK/SIRT1 signaling proteins to inhibit p38MAPK proteins. With the use of in vitro oxidative-stress-induced hepatocytes and myoblasts models, DR2 was also shown to be able to reduce oxidative stress aggravation through mediation of Nrf2-related antioxidative cascade, reduce intracellular lipid accumulation through phosphorylation of ACC protein, reduce lipid peroxidation in hepatocytes and promote insulin sensitivity via activation of AKT protein in the insulin-resistant HepG2 cells and C2C12 cells. The effects of DR2 on adipogenesis, lipid accumulation, insulin resistance and blood glucose clearance were further demonstrated in the high-fat diet-induced obesity mouse model. Our in vitro and in vivo studies determined that DR2 could contain therapeutic potential for the treatment of obesity and type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Teaching and Research Division, School of Chinese Medicine, Hong Kong Baptist University, Kowloon, Hong Kong, China.
ORCID-Profile: Chu-Shing Lam, Yi-Xuan Xia, Bai-Sen Chen, Kang-Lun Liu, Hong-Jie Zhang
Förderung
- Government of Hong Kong
- Research Grants Council of the Hong Kong Special Administrative Region, China
- Government of the Hong Kong Special Administrative Region
Zitieren
APA
Lam, C. S., Xia, Y. X., Chen, B. S., Du, Y. X., Liu, K. L., & Zhang, H. J. (2023). Dihydro-Resveratrol Attenuates Oxidative Stress, Adipogenesis and Insulin Resistance in In Vitro Models and High-Fat Diet-Induced Mouse Model via AMPK Activation. Nutrients. https://doi.org/10.3390/nu15133006
Vancouver
Lam CS, Xia YX, Chen BS, Du YX, Liu KL, Zhang HJ. Dihydro-Resveratrol Attenuates Oxidative Stress, Adipogenesis and Insulin Resistance in In Vitro Models and High-Fat Diet-Induced Mouse Model via AMPK Activation. Nutrients. 2023. doi:10.3390/nu15133006
BibTeX
@article{Lam2023,
author = {Lam, Chu-Shing and Xia, Yi-Xuan and Chen, Bai-Sen and Du, Yin-Xiao and Liu, Kang-Lun and Zhang, Hong-Jie},
title = {Dihydro-Resveratrol Attenuates Oxidative Stress, Adipogenesis and Insulin Resistance in In Vitro Models and High-Fat Diet-Induced Mouse Model via AMPK Activation},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15133006}
}
EUVIMED